INVESTMENT

Citi maintains Ascendis Pharma stock at Buy, positive outlook ahead of pivotal trial data

Tomas Kauer - ModeratorTomas Kauer - Moderator
Sep 10, 2024 - 18:00
Citi maintains Ascendis Pharma stock at Buy, positive outlook ahead of pivotal trial data
Read More

Tags:

Previous Article

Rubrik stock shines with raised guidance and strong cloud growth

Next Article

Morgan Stanley raises FCC Co stock outlook, targets 15% upside

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Tomas Kauer - Moderator
Tomas Kauer - Moderator

Related Posts

Michigan Supreme Court rules RFK Jr to stay on state's presidential ballot

Michigan Supreme Court rules RFK Jr to stay on state's ...

Tomas Kauer - Mode... Sep 10, 2024

After selling Drift, ex-HubSpot exec launches AI for customer success managers

After selling Drift, ex-HubSpot exec launches AI for cu...

Tomas Kauer - Mode... Oct 17, 2024

Initialized Capital restructures, and lets multiple partners go

Initialized Capital restructures, and lets multiple par...

Tomas Kauer - Mode... Oct 4, 2024